Angiodynamic (ANGO) has a PEG ratio of -20.35, below the Healthcare sector average of 2.56.
Get informed when a big investor buys or sells
+ Follow-20.35
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
Angiodynamic (ANGO) currently reports a PEG ratio of -20.35. That is below the Healthcare sector average of 2.56. Use the charts on this page to explore Angiodynamic's PEG ratio history and peer comparisons.
Angiodynamic's PEG ratio of -20.35 is lower than the Healthcare sector average of 2.56. That is roughly 895.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The PEG ratio is a valuation multiple that relates Angiodynamic's market price to a fundamental measure such as earnings, sales, or book value. At -20.35, ANGO can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current PEG ratio of -20.35, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 2.56. From there, open related valuation or income-statement pages for Angiodynamic, and consider following ANGO for alerts when major investors trade the stock.
Angiodynamic is classified in the Healthcare sector. On PEG ratio, it currently shows -20.35 versus a sector average near 2.56. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ANGO with unrelated industries.